60 Degrees Pharmaceuticals, Inc.
SXTP
$1.61
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.32M | 1.41M | 1.37M | 984.50K | 802.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32M | 1.41M | 1.37M | 984.50K | 802.30K |
| Cost of Revenue | 2.77M | 2.85M | 2.82M | 2.53M | 5.41M |
| Gross Profit | -1.46M | -1.44M | -1.46M | -1.54M | -4.61M |
| SG&A Expenses | 6.48M | 6.32M | 6.45M | 6.16M | 5.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.26M | 9.17M | 9.27M | 8.68M | 11.09M |
| Operating Income | -7.94M | -7.76M | -7.91M | -7.70M | -10.28M |
| Income Before Tax | -7.58M | -7.37M | -7.98M | -7.82M | -10.26M |
| Income Tax Expenses | 0.00 | 0.00 | 1.00K | 1.00K | -100.00 |
| Earnings from Continuing Operations | -7.58 | -7.37 | -7.98 | -7.82 | -10.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.30K | 3.20K | 6.60K | 6.60K | 6.90K |
| Net Income | -7.58M | -7.37M | -7.97M | -7.82M | -10.25M |
| EBIT | -7.94M | -7.76M | -7.91M | -7.70M | -10.28M |
| EBITDA | -7.85M | -7.68M | -7.83M | -7.63M | -10.23M |
| EPS Basic | -10.47 | -15.40 | -23.03 | -39.01 | -118.51 |
| Normalized Basic EPS | -6.11 | -9.01 | -13.51 | -22.98 | -71.42 |
| EPS Diluted | -10.47 | -15.40 | -23.03 | -39.01 | -118.51 |
| Normalized Diluted EPS | -6.11 | -9.01 | -13.51 | -22.98 | -71.42 |
| Average Basic Shares Outstanding | 4.08M | 2.67M | 1.85M | 1.05M | 732.80K |
| Average Diluted Shares Outstanding | 4.08M | 2.67M | 1.85M | 1.05M | 732.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |